ABBV Options Signal Deep Bearish Sentiment as Put Open Interest Dwarfs Calls—Is $200 the Next Key Level?

• ABBV drops nearly 3.1% today, breaking below key 30D support at $224.
• Put/call open interest ratio stands at 1.04, with puts dominating near $200 strike.
• Strong news on earnings and Horizon acquisition clash with short-term selling pressure.
• Options data suggests sharp bearish positioning ahead of Friday’s expiry.

If you're watching ABBV today, the options market is sending a clear message: the bears are in control. With a nearly 3% drop after a long-term range-bound pattern, and a bearish engulfing candle forming on the charts, the mood is shifting. Let’s break down what the numbers and news are telling us—and what to do about it.

Bearish Options Pile Up at $200 Strike—What It Means

Options open interest is skewed to the downside, with puts near $200 ($200OI:2571) dominating over calls. That means a lot of traders are either hedging or outright betting on a drop below that level. The next expiration is Friday, and the $200 strike is the most active put. A close below $210 would likely trigger more aggressive put buyers, especially with ABBV already below its 200D MA at $216.07.

Meanwhile, block trading is quiet—no whale moves today. That’s good news if you want to trade based on open interest, as it suggests the options-driven bearish bias is more organic than forced. The call skew isn’t strong enough to suggest a rebound is being priced in, though a few calls at $215 ($215OI:388) and $217.5 ($217.5OI:430) could hint at some support-level buying.

The MACD histogram is positive, but not enough to tip the balance—RSI is still in oversold territory at 37.8, which could suggest the drop has more room to run before a bounce. But the RSI isn’t screaming for a rebound yet. This is a stock that’s been in a tight range for months and now looks like it’s breaking out—south.

Big News vs. Big Moves: What’s in the Headlines

ABBV’s story is not one of collapse—it’s one of strategic evolution. The company just raised full-year guidance and announced a $26.8B acquisition of Horizon Therapeutics. It’s also spinning off its medical device unit, securing financing for its deals, and launching new neuroscience products.

But here’s the rub: these are long-term moves. The stock is getting hammered by the market’s short-term skepticism. It’s the same pattern we’ve seen with other Big Pharma names—long-term growth plans vs. near-term profit concerns. The recent 10% swing in stock price reflects that tension. The news is bullish, but the market is bearish. So right now, the stock looks like it’s stuck in a tug-of-war between fundamentals and sentiment.

Trading Ideas for ABBV Today: Calls to Defend and Puts to Profit

For options players, the most interesting plays are either defensive or directional:

• Bearish Plays: Buy the $200P for Friday (2026-04-03). With 2571 contracts in open interest, this strike has seen heavy bearish buildup. If ABBV closes below $210 before expiration, the $200P could run. Entry should be at or below $210, with a target around $205–$200.

• Neutral to Slightly Bullish Plays: Buy the $215C or $217.5C for Friday (2026-04-03). These strikes offer a balance between support and potential bounce setups. If ABBV holds above $207.71 (intraday low) and the RSI turns, these calls could capitalize on a rebound to $215–$220.

For stock players: a bounce to $210 could be a key retest of support. Consider entry near $210–$212 with a stop just below $207.71. If it fails there, the next key level is $200. If it holds, a rebound into $215–$220 is possible.

Volatility on the Horizon—Is This the Start of a New Trend?

ABBV is at a critical crossroads. The options market is bearish in the short term, but the fundamentals are bullish over the next 6–12 months. The key is whether the stock can stabilize at or above $210. If it can’t, the $200 level becomes a serious target for bears. But if it can hold, the RSI bounce and support at $215 could spark a rebound into April 10th and beyond. The next few sessions will tell us whether this is a bearish breakout or a short-term pullback. Either way, the market is watching—and so should you.